Regenerative Medical Solutions, nestled in the heart of Madison, Wisconsin, is a beacon of innovation within the realm of islet cell research. We excel in delivering advanced therapies such as ILC Cell Technology and Therapeutics pivotal for treating diabetes effectively. Our team’s expertise in Pancreatic Beta Cell Development has enabled us to create the revolutionary ProgenMix™ Media Formulation, which enhances stem cell cultivation processes essential for groundbreaking islet therapy. Through RMS Consulting Services, we extend our knowledge base to support other entities striving towards excellence in beta cell replacement therapies. We maintain an active role in Diabetes Research and Solutions by contributing valuable insights through scientific publications while securing patents & licenses that solidify our position as thought leaders. Our relentless pursuit of advancing Stem Cell-Based Islet Therapy demonstrates our unwavering commitment to transforming diabetes care for a better tomorrow.